Part: 12         Session: 123456789101112131415161718192021222324252627282930313233343536         Page 182183184185186187188189190191192193194195196196197198199200201202203204205206207208209210211212 of 1143

in other parts of the world which are less well organized against them than the United States.

From this beginning in 1948, the National Heart Institute has at present for research and education of research workers $155,742,000, and I've been with the Heart Council twice and we still have not got the answer to arteriosclerosis. However, major diseases like high blood pressure, there are new drugs and there have been advances in the knowledge of how to prevent rheumatic fever. Heart surgery in the United States is at a stage not known before or in any other place of the world, due in large part to the Heart Institute. And we're on the verge of large clinical trials on the usefulness of nicotinic acid, thyroid analog, and premarin, to see if any of these drugs, alone or in some combination, may reduce the death rate. These trials are about to be started by both the Heart Institute and the Veterans Administration. As a matter of fact, they have been just begun by the Veterans Administration. This is the result of two pieces of heart research financed initially by me in one case--that is, by the Lasker Foundation--and one by the Heart Institute and partly by us. The two groups that are involved are Dr. Jesse's group at the University of Southern California and Dr. Katz's and Dr. Stammler's group at Hospital in Chicago. They have both shown that premarin given in different doses reduces the death rate after heart attack in young men.